Skip to content

LONA LONA Change in AP

Change in AP at other companies

Eli Lilly logo
Eli LillyLLY
$2.55B+290%
Arvinas logo
ArvinasARVN
-$6.8M-750%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$5.68M-31.8%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$1.02M+444%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$2.82M+898%
Erasca, Inc. logo
Erasca, Inc.ERAS
$1.18M-34.1%

Other financials

Income statement

See full
Operating income-$17.2M-80.5%
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+223%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's change in AP?
LONA (LONA) reported change in AP of -$3.36M in Q1 2026.
How has LONA's change in AP changed year-over-year?
LONA's change in AP increased by 56.1% year-over-year, from -$7.66M to -$3.36M.
What is the long-term trend for LONA's change in AP?
Over 3 years (2021 to 2025), LONA's change in AP has grown at a 60.6% compound annual growth rate (CAGR), from $5.15M to -$21.34M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.